Study of RP-3500, Camonsertib, in Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- #2001, Princess Margaret Cancer Centre
Toronto, Ontario, Canada
- #4001, Copenhagen University Hospital Rigshospitalet - Blegdamsvej
Copenhagen, DK, Denmark
- #3003, Sarah Cannon Research Institute
London, United Kingdom
- #3001, the Christie Nhs Foundation Trust
Manchester, United Kingdom
- #3002, Freeman Hospital Newcastle
Newcastle upon Tyne, United Kingdom
- #1014, Northwestern University
Chicago, Illinois, United States
- #1002, Dana Farber Cancer Institute
Boston, Massachusetts, United States
- #1006, Massachusetts General Hospital
Boston, Massachusetts, United States
- #1004, Memorial Sloan Kettering Cancer Institute
New York, New York, United States
- #1005, Duke Cancer Institute
Durham, North Carolina, United States
- #1007, Rhode Island Hospital
Providence, Rhode Island, United States
- #1003, Sarah Cannon Research Institute
Nashville, Tennessee, United States
- #1001, the University of Texas M.D. Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Jul 2020
- Primary completion
- 13 Jun 2025
- Completion
- 13 Jun 2025
- Last update posted
- 21 Oct 2025
- Registered enrollment
- 276
- Registry id
- NCT04497116
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.